Cargando…

Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients

Somatostatin has been extensively studied for the prophylaxis of pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP). However, the results remain controversial. The present retrospective cohort study aimed to investigate the efficacy of pre- and post-ERCP somatostatin admini...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHAO, LI-NA, YU, TAO, LI, CHU-QIANG, LAI, YU, CHEN, QI-KUI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079433/ https://www.ncbi.nlm.nih.gov/pubmed/25009610 http://dx.doi.org/10.3892/etm.2014.1733

Ejemplares similares

Reduced risk of post ERCP pancreatitis in statin users
por: Hadi, Yousaf Bashir, et al.
Publicado: (2020)

Role of Somatostatin in Preventing Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: An Update Meta-analysis
por: Hu, Jing, et al.
Publicado: (2016)

Prophylactic Effect of Somatostatin in Preventing Post-ERCP Pancreatitis: An Updated Meta-Analysis
por: Qin, Xie, et al.
Publicado: (2015)

The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
por: Kim, Joo Seong, et al.
Publicado: (2022)

Prevention of Post-ERCP Pancreatitis
por: Donnellan, F., et al.
Publicado: (2012)

Post-ERCP acute pancreatitis and its risk factors
por: Iorgulescu, A, et al.
Publicado: (2013)

Adverse events in endoscopic retrograde cholangiopancreaticography (ERCP): Focus on post‐ERCP‐pancreatitis
por: Hollenbach, Marcus, et al.
Publicado: (2022)

Prognosis and risk factors of ERCP pancreatitis in elderly
por: Ergin, Erhan, et al.
Publicado: (2021)

Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis
por: Nawaz, Muhammad Haseeb, et al.
Publicado: (2020)

Three-hour post-ERCP amylase level: a useful indicator for early prediction of post-ERCP pancreatitis
por: Lv, Ze-Hui, et al.
Publicado: (2020)

Is ESR Important for Predicting Post-ERCP Pancreatitis?
por: Mohammad Alizadeh, Amir Houshang, et al.
Publicado: (2015)

Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
por: Cahyadi, Oscar, et al.
Publicado: (2022)

Pancreatic Stenting Reduces Post-ERCP Pancreatitis and Biliary Sepsis in High-Risk Patients: A Randomized, Controlled Study
por: Yin, He-Kun, et al.
Publicado: (2016)

Early ERCP in Biliary Pancreatitis?
por: Finch, Margaret D., et al.
Publicado: (1998)

Nonradiation-to-endoscopist ERCP is non-inferior to standard ERCP
por: Zeng, Wei, et al.
Publicado: (2021)

Is Post-ERCP Pancreatitis a Genetically Predisposed Complication?
por: Mystakidis, Konstantinos, et al.
Publicado: (2012)

UK wide survey on the prevention of post-ERCP pancreatitis
por: Hanna, Mina S, et al.
Publicado: (2014)

Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both?
por: van Wanrooij, R. L. J., et al.
Publicado: (2019)

Reducing radiation risks during ERCP: less is more
por: Savides, Thomas J.
Publicado: (2012)

Evaluation of guide wire cannulation in reduced risk of post - ERCP pancreatitis and facilitated bile duct cannulation
por: Savadkoohi, Shahriar, et al.
Publicado: (2012)

Author Correction: Prognosis and risk factors of ERCP pancreatitis in elderly
por: Ergin, Erhan, et al.
Publicado: (2021)

The modified pancreatic stent system for prevention of post-ERCP pancreatitis: a case-control study
por: Zhang, Cheng, et al.
Publicado: (2017)

The future of ERCP
por: Kozarek, Richard A.
Publicado: (2017)

Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
por: Zheng, Minghua, et al.
Publicado: (2008)

Combination of diclofenac and aggressive hydration for the prevention of post-ERCP pancreatitis
por: Hajalikhani, Mehri, et al.
Publicado: (2018)

Prevention of post-ERCP pancreatitis: current strategies and novel perspectives
por: Borrelli de Andreis, Federica, et al.
Publicado: (2023)

The Polymorphisms at PRSS1-PRSS2 and MORC4 Loci and the Risk of Post-ERCP Pancreatitis
por: Angsuwatcharakon, Phonthep, et al.
Publicado: (2018)

Factors and Outcomes Associated with MRCP Use prior to ERCP in Patients at High Risk for Choledocholithiasis
por: Anand, Gobind, et al.
Publicado: (2016)

Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial
por: Phillip, Veit, et al.
Publicado: (2019)

ERCP in Evaluating The Mode of Therapy in Pancreatic Pseudocyst
por: Nordback, I., et al.
Publicado: (1988)

ERCP-associated infected intrahepatic pancreatic pseudocyst
por: Angsubhakorn, Natthapon, et al.
Publicado: (2019)

Roles of ERCP in the Early Diagnosis of Pancreatic Cancer
por: Hanada, Keiji, et al.
Publicado: (2019)

EUS and ERCP partnership
por: Binda, Cecilia, et al.
Publicado: (2021)

Splenic Injury and ERCP: A Possible Risk for Patients with Advanced Chronic Pancreatitis
por: Gaffney, Ryan R., et al.
Publicado: (2012)

Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
por: Issak, Abdulfatah, et al.
Publicado: (2021)

Risk factors for post-ERCP cholecystitis: a single-center retrospective study
por: Cao, Jun, et al.
Publicado: (2018)

The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients
por: Aghajanpoor Pasha, Morteza, et al.
Publicado: (2020)

Role of ERCP in acute biliary pancreatitis: yet unanswered
por: Birda, Chhagan Lal, et al.
Publicado: (2021)

Ketamine Use for Successful Resolution of Post-ERCP Acute Pancreatitis Abdominal Pain
por: Agerwala, Suneel M., et al.
Publicado: (2017)

Predictors of Post-ERCP Pancreatitis (P.E.P.) in Choledochal Lithiasis Extraction
por: Boicean, Adrian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qpt9nc38helkff26j17bgmr9re